American Portfolios Advisors’s Titan Pharmaceuticals TTNP Stock Holding History

American Portfolios Advisors’s Portfolio TTNP Stock Details TTNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$25	Hold	1	–	–	﹤0.01%	3518
2022 Q2	$13	Hold	1	–	–	﹤0.01%	3521
2022 Q1	$22	Hold	1	–	–	﹤0.01%	3576
2021 Q4	$23	Hold	1	–	–	﹤0.01%	3498
2021 Q3	$43	Hold	1	–	–	﹤0.01%	3456
2021 Q2	$60	Hold	1	–	–	﹤0.01%	3381
2021 Q1	$69	Hold	1	–	–	﹤0.01%	3260
2020 Q4	$76	Hold	1	–	–	﹤0.01%	2957
2020 Q3	$103	Hold	1	–	–	﹤0.01%	2916
2020 Q2	$191	Hold	1	–	–	﹤0.01%	2802
2020 Q1	$145	Hold	1	–	–	﹤0.01%	2730
2019 Q4	$121	Hold	1	–	–	﹤0.01%	2791
2019 Q3	$123	Hold	1	–	–	﹤0.01%	2777
2019 Q2	$584	Hold	1	–	–	﹤0.01%	2637
2019 Q1	$812	Hold	1	–	–	﹤0.01%	2497
2018 Q4	$609	Hold	1	–	–	﹤0.01%	2297
2018 Q3	$565	Hold	1	–	–	﹤0.01%	2335
2018 Q2	$2.98K	Hold	1	–	–	﹤0.01%	2120
2018 Q1	$2.87K	Hold	1	–	–	﹤0.01%	2027
2017 Q4	$3.62K	Buy	+1	New	+$6.22K	﹤0.01%	1937

Other funds holding TTNP

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

American Portfolios Advisors's TTNP Position: Q3 2022 in Review

American Portfolios Advisors held its Titan Pharmaceuticals (TTNP) position steady in Q3 2022 at 1 share worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #3518.

American Portfolios Advisors first reported a position in TTNP in Q4 2017 and has held it in 20 quarters since. The position peaked at $3.62K in Q4 2017. 18 funds tracked by Wall St. Rank hold TTNP as of Q3 2022.

American Portfolios Advisors held 1 share of Titan Pharmaceuticals worth $25 as of Q3 2022.
American Portfolios Advisors left its Titan Pharmaceuticals share count unchanged in Q3 2022.
Titan Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3518 holding.
American Portfolios Advisors first reported a position in Titan Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
American Portfolios Advisors's Titan Pharmaceuticals position peaked at $3.62K in Q4 2017.
18 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.